Beijing Beilu Pharmaceutical Co., Ltd - PE Ratio

The PE Ratio as of July 2026 (TTM) for Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) is 64.43

According to Beijing Beilu Pharmaceutical Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 64.43. This represents a change of 22.20% compared to the average of 52.72 of the last 4 quarters.

Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) Historical PE Ratio (quarterly & annually)

How has 300016.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Beijing Beilu Pharmaceutical Co., Ltd over the last ten years is 103.45. The current 64.43 PE Ratio has changed 6.13% with respect to the historical average. Over the past ten years (40 quarters), 300016.SZ's PE Ratio was at its highest in in the June 2022 quarter at 1.26K. The PE Ratio was at its lowest in in the June 2023 quarter at -263.49.

Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Beijing Beilu Pharmaceutical Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) Average PE Ratio

How has 300016.SZ PE Ratio performed in the past?

The current PE Ratio of Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) PE Ratio vs. Peers

How is 300016.SZ’s PE Ratio compared to its peers?

Beijing Beilu Pharmaceutical Co., Ltd’s PE Ratio is less than Qianjiang Yongan Pharmaceutical Co., Ltd. (102.42), greater than Ningbo Menovo Pharmaceutical Co., Ltd. (62.28), greater than Tibet Weixinkang Medicine Co., Ltd. (17.94), greater than HPGC Renmintongtai Pharmaceutical Corporation (37.19), less than Jinling Pharmaceutical Company Limited (66.21), less than LanZhou Foci Pharmaceutical Co.,Ltd. (75.29), greater than Hunan Fangsheng Pharmaceutical Co., Ltd. (13.99), greater than Yabao Pharmaceutical Group Co., Ltd (14.52), less than Zhejiang Starry Pharmaceutical Co.,Ltd. (184.88), less than Jinhe Biotechnology Co. Ltd. (114.12),

Build a custom stock screener for Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beijing Beilu Pharmaceutical Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beijing Beilu Pharmaceutical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.